Nov 4, 2025 07:00AM
May 15, 2025 08:00AM
Feb 11, 2025 09:15AM
Jan 22, 2025 04:31PM
Jan 22, 2025 04:05PM
Jan 10, 2025 08:03AM
Jan 10, 2025 08:00AM Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
Jan 8, 2025 07:01AM
Jan 8, 2025 07:00AM
Jan 8, 2025 07:00AM
Dec 17, 2024 07:00AM
Dec 4, 2024 07:01AM
Dec 4, 2024 07:00AM
Nov 19, 2024 07:02AM Tiziana Life Sciences (TLSA) Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Nov 19, 2024 07:00AM
Nov 1, 2024 01:00PM
Oct 30, 2024 08:33AM
Oct 30, 2024 08:30AM
Sep 19, 2024 07:02AM
Sep 19, 2024 07:00AM
Aug 19, 2024 07:00AM Tiziana Life Sciences (TLSA) Appoints Ivor Elrifi as CEO
Aug 19, 2024 07:00AM
Aug 14, 2024 07:04AM
Aug 14, 2024 07:00AM
Jul 24, 2024 07:00AM
Jul 24, 2024 07:00AM
Jun 26, 2024 07:00AM
Jun 11, 2024 08:45AM Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
Jun 11, 2024 08:03AM
Jun 11, 2024 08:00AM
Jun 6, 2024 09:03AM
Jun 6, 2024 09:00AM
Jun 4, 2024 09:02AM
Jun 4, 2024 09:00AM
May 30, 2024 07:00AM Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
May 13, 2024 07:04AM
May 13, 2024 07:00AM
Apr 23, 2024 07:01AM
Apr 23, 2024 07:00AM
Dec 19, 2023 07:00AM
Oct 18, 2023 07:04AM
Oct 13, 2023 07:07AM Tiziana (TLSA) Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS
Sep 6, 2023 07:03AM
Sep 6, 2023 07:00AM
Aug 17, 2023 07:00AM
Aug 15, 2023 07:05AM
Apr 26, 2023 02:47PM
Apr 26, 2023 02:47PM
Apr 20, 2023 07:02AM Tiziana Life Sciences (TLSA) to File Alzheimer’s IND for Intranasal Foralumab in Q2 2023
Apr 20, 2023 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All